Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol.

BMJ open - 4 Sept 2018

Dossa Fahima, Cusimano Maria C, Sutradhar Rinku, Metcalfe Kelly, Little Tari, Lerner-Ellis Jordan, Eisen Andrea, Meschino Wendy S, Baxter Nancy N

Abstract excerpt

INTRODUCTION: Women who have pathogenic mutations in the BRCA1 and BRCA2 genes are at greatly increased risks for breast and ovarian cancers. Although risk-reduction strategies can be undertaken by these women, knowledge regarding the uptake of these strategies is limited. Additionally, the healthcare behaviours of women who receive inconclusive test results are not known. This study protocol describes the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Frequency
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Genetic Testing

Share to Incidence

Share to Ontario

Share to Patient Acceptance of Health Care

Share to Research Design

Source

Open in PubMed Open full text

Identifiers

PMID: 30181190
DOI: 10.1136/bmjopen-2018-025317
PMCID: PMC6129086

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol.PMID 30181190Read ↗

Building the What Comes Next Cohort for BRCA1 and BRCA2 testing: a descriptive analysis.Semantic proximity Read ↗

Suboptimal Adherence to Hereditary Cancer Risk Management Guidelines: A Cohort Study of High-Risk Individuals in Newfoundland and Labrador, Canada.Semantic proximity Read ↗

Genetic testing for BRCA1 and BRCA2 in the Province of Ontario.Semantic proximity Read ↗

Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program.Semantic proximity Read ↗

Breast and Ovarian Cancer Among Individuals Undergoing BRCA1 and BRCA2 Testing.Semantic proximity Read ↗

Factors influencing genetic counseling and testing for hereditary breast and ovarian cancer syndrome in a large US health care system.Semantic proximity Read ↗

Canadian Recommendations for Germline Genetic Testing of Patients with Breast Cancer: A Call to ActionSemantic proximity Read ↗

Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Specialty Care and Counselling about Hereditary Cancer Risk Improves Adherence to Cancer Screening and Prevention in Newfoundland and Labrador Patients with <em>BRCA1/2</em> Pathogenic Variants: A Population-Based Retrospective Cohort StudySemantic proximity Read ↗

National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.Semantic proximity Read ↗

Selected Medical Interventions in Women With a Deleterious Brca Mutation: A Population-Based Study in British ColumbiaSemantic proximity Read ↗

Socioeconomic and Clinical Determinants Driving Access to BRCA Genetic Testing in Cancer : A Case-Control Study Using Observational Electronic Health Records Across Multiple SitesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.